TABLE 1. Characteristics of contacts* of confirmed or probable COVID-19† patients enrolled in an automated, web-based symptom monitoring tool (Sara Alert) — Maine, May 14–June 26, 2020.
| Characteristic | No. (%) |
|---|---|
|
Total no. of persons enrolled
|
1,622 (100)
|
|
Age at enrollment, yrs, median (range)
|
29 (0–93) |
|
Sex
| |
| Female |
766 (50.3) |
| Male |
757 (49.7) |
| Not reported |
99 (—) |
|
Race
| |
| American Indian/Alaska Native |
5 (0.4) |
| Asian/Pacific Islander |
17 (1.4) |
| Black/African American |
486 (39.2) |
| White |
732 (59.0) |
| Not reported |
382 (—) |
|
Ethnicity
| |
| Hispanic or Latino |
42 (4.1) |
| Not Hispanic or Latino |
978 (95.9) |
| Not reported |
602 (—) |
|
Primary language
| |
| American Sign Language |
6 (0.5) |
| Arabic |
8 (0.7) |
| English |
985 (80.1) |
| French |
86 (7.0) |
| Kirundi |
8 (0.7) |
| Lingala |
11 (0.9) |
| Portuguese |
10 (0.8) |
| Somali |
81 (6.6) |
| Spanish |
19 (1.5) |
| Other |
16 (1.4) |
| Not reported |
392 (—) |
|
County
| |
| Androscoggin |
421 (26.9) |
| Aroostook |
39 (2.5) |
| Cumberland |
713 (45.6) |
| Franklin |
12 (0.8) |
| Hancock |
2 (0.3) |
| Kennebec |
60 (3.8) |
| Knox |
1 (0.1) |
| Lincoln |
8 (0.5) |
| Oxford |
32 (2.1) |
| Penobscot |
17 (1.1) |
| Sagadahoc |
25 (1.6) |
| Somerset |
9 (0.6) |
| Waldo |
3 (0.2) |
| Washington |
14 (0.9) |
| York |
193 (12.4) |
| Out of state |
10 (0.6) |
| Missing | 59 (—) |
Abbreviation: COVID-19 = coronavirus disease 2019.
* Defined as persons who were within 6 feet of an infectious person (symptomatic persons, 2 days before symptom onset to at least 10 days following symptom onset; asymptomatic persons, 2 days before collection of a specimen that resulted in a positive test to 10 days following specimen collection date) for ≥15 minutes (≥30 minutes before May 29).
† Probable cases had either clinical criteria or epidemiologic evidence of exposure (contact with a person with a confirmed or probable COVID-19 case or contact with a person with clinically compatible illness or linkage to a person with confirmed COVID-19), or met vital records criteria (a death certificate listing COVID-19 or SARS-CoV-2 as a cause of death or a significant condition contributing to death with no confirmatory laboratory testing performed for COVID-19). Confirmed cases had confirmatory laboratory evidence of SARS-CoV-2 infection. COVID-19 signs and symptoms included cough, difficulty breathing, fever, chills, shaking with chills (rigors), muscle pain, headache, sore throat, and new loss of taste or smell.